ES8103061A1 - Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina - Google Patents

Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina

Info

Publication number
ES8103061A1
ES8103061A1 ES491000A ES491000A ES8103061A1 ES 8103061 A1 ES8103061 A1 ES 8103061A1 ES 491000 A ES491000 A ES 491000A ES 491000 A ES491000 A ES 491000A ES 8103061 A1 ES8103061 A1 ES 8103061A1
Authority
ES
Spain
Prior art keywords
pirimidine
isopropylamine
procedure
preparation
hydroxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES491000A
Other languages
English (en)
Spanish (es)
Other versions
ES491000A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes de Produits Chimiques SA
Original Assignee
Societe dEtudes de Produits Chimiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes de Produits Chimiques SA filed Critical Societe dEtudes de Produits Chimiques SA
Publication of ES491000A0 publication Critical patent/ES491000A0/es
Publication of ES8103061A1 publication Critical patent/ES8103061A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES491000A 1979-04-30 1980-04-29 Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina Expired ES8103061A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
ES491000A0 ES491000A0 (es) 1981-02-16
ES8103061A1 true ES8103061A1 (es) 1981-02-16

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
ES491000A Expired ES8103061A1 (es) 1979-04-30 1980-04-29 Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina
ES490999A Expired ES8103060A1 (es) 1979-04-30 1980-04-29 Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES490999A Expired ES8103060A1 (es) 1979-04-30 1980-04-29 Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina

Country Status (26)

Country Link
JP (2) JPS55145671A (online.php)
AR (2) AR222869A1 (online.php)
AT (2) AT380012B (online.php)
BE (2) BE882593A (online.php)
CH (2) CH645633A5 (online.php)
DK (2) DK183880A (online.php)
EG (2) EG14284A (online.php)
ES (2) ES8103061A1 (online.php)
FI (2) FI66359C (online.php)
FR (2) FR2455589A1 (online.php)
GB (2) GB2054556B (online.php)
HK (2) HK55583A (online.php)
IE (2) IE49709B1 (online.php)
IN (2) IN154067B (online.php)
IT (2) IT1141296B (online.php)
LU (2) LU82332A1 (online.php)
MA (1) MA18824A1 (online.php)
MX (2) MX5878E (online.php)
MY (2) MY8400203A (online.php)
NL (2) NL8002272A (online.php)
NO (2) NO154055C (online.php)
NZ (2) NZ193421A (online.php)
OA (2) OA06525A (online.php)
PT (2) PT71154A (online.php)
SG (2) SG22583G (online.php)
ZA (2) ZA801958B (online.php)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (online.php) * 1987-03-13 1988-09-26
JPS645795U (online.php) * 1987-06-26 1989-01-13
JPH01100695U (online.php) * 1987-12-21 1989-07-06
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
USD500447S1 (en) * 2003-08-07 2005-01-04 Kranson Industries Oval bottle
USD505864S1 (en) * 2003-08-07 2005-06-07 Kranson Industries Oval bottle

Also Published As

Publication number Publication date
IN154066B (online.php) 1984-09-15
IT1141487B (it) 1986-10-01
JPS6116272B2 (online.php) 1986-04-28
MY8400203A (en) 1984-12-31
ES491000A0 (es) 1981-02-16
ES490999A0 (es) 1981-02-16
ZA801958B (en) 1981-04-29
FI801083A7 (fi) 1980-10-31
LU82333A1 (fr) 1980-07-02
FR2455589B1 (online.php) 1981-07-10
NO154055B (no) 1986-04-01
MX6514E (es) 1985-06-26
GB2054556B (en) 1983-01-26
IT8021543A0 (it) 1980-04-22
NZ193421A (en) 1981-11-19
FI66359C (fi) 1984-10-10
MA18824A1 (fr) 1980-12-31
JPS6116273B2 (online.php) 1986-04-28
JPS55145670A (en) 1980-11-13
BE882594A (fr) 1980-07-31
BE882593A (fr) 1980-07-31
GB2055801A (en) 1981-03-11
NO801235L (no) 1980-10-31
GB2054556A (en) 1981-02-18
LU82332A1 (fr) 1980-07-02
GB2055801B (en) 1983-02-09
NO154055C (no) 1986-07-09
ZA801960B (en) 1981-04-29
MY8400204A (en) 1984-12-31
AR222869A1 (es) 1981-06-30
CH645361A5 (en) 1984-09-28
SG22283G (en) 1983-12-16
PT71155A (en) 1980-05-01
IT8021542A0 (it) 1980-04-22
IE800864L (en) 1980-10-30
OA06527A (fr) 1981-07-31
ATA221680A (de) 1985-08-15
NL8002271A (nl) 1980-11-03
OA06525A (fr) 1981-07-31
FI66358C (fi) 1984-10-10
ES8103060A1 (es) 1981-02-16
FI66358B (fi) 1984-06-29
AR222870A1 (es) 1981-06-30
NZ193422A (en) 1981-12-15
IE49709B1 (en) 1985-11-27
NO801234L (no) 1980-10-31
AT380012B (de) 1986-03-25
DK183880A (da) 1980-10-31
HK55583A (en) 1983-11-25
JPS55145671A (en) 1980-11-13
NO154056C (no) 1986-07-09
FR2455588A1 (fr) 1980-11-28
CH645633A5 (en) 1984-10-15
HK55683A (en) 1983-11-25
NL8002272A (nl) 1980-11-03
IN154067B (online.php) 1984-09-15
ATA221580A (de) 1985-08-15
IT1141296B (it) 1986-10-01
FI66359B (fi) 1984-06-29
IE49591B1 (en) 1985-10-30
PT71154A (en) 1980-05-01
NO154056B (no) 1986-04-01
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
EG14284A (en) 1983-09-30
DK183780A (da) 1980-10-31
AT380013B (de) 1986-03-25
SG22583G (en) 1983-12-16
FR2455588B1 (online.php) 1983-04-15
FI801084A7 (fi) 1980-10-31
MX5878E (es) 1984-08-16
FR2455589A1 (fr) 1980-11-28

Similar Documents

Publication Publication Date Title
BE839805R (fr) Procede de preparation de dispersions d'aminoplastes
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
PH15281A (en) Pyrimido(6,1-a)isoquinolin-4-ones
FR2416218A1 (fr) Procede de preparation de n-(p-aminobenzoyl) glutamates de dialkyle
FR2357553A1 (fr) Procede de preparation de benzothiazoles
FR2433504A1 (fr) Procede de preparation de derives du biphenyle
BE883909A (fr) Procede de preparation de chloro-2proprionate d'alcoyle par chloration de lactate d'alcoyle
DE3167774D1 (en) 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
SE8001812L (sv) Nya hydroxipyrimidinderivat och sett for framstellning derav
FR2377367A1 (fr) Procede de preparation d'alcoxy-cetones
ES519532A0 (es) Procedimiento de preparacion de derivados de imidazolidina.
ES511365A0 (es) "procedimiento de preparacion de derivados de fenetanolamina".
ES516158A0 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
FR2385672A1 (fr) Procede de preparation d'halogeno-cyclobutanones
FR2429211A1 (fr) Procede de production de derives de n-methylbenzothiazolone substitues en position 4
ES500980A0 (es) Procedimiento de preparar alcoxi propanolaminas
FR2374316A1 (fr) Derives de morpholine utilisables comme fongicides
FR2362808A1 (fr) Procede de preparation de 2-alkyl-2-methylpropane-1,3-diols
MX157221A (es) Procedimiento para preparar derivados de delta 1,3,5-3-cloro-pregnano
FR2416223A1 (fr) Derives de phenylpyrol utilisables comme fongicides
PT67685A (fr) Procede de preparation de derives 17 alpha-acetyleniques de l'androst-4-ene
FR2372805A1 (online.php)
FR2442838A1 (fr) Procede de preparation de mercapto-5 triazoles-1,2,3
ZA807905B (en) 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof